Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Pomerium
start up
United States
- Los Angeles, California
- 21/06/2024
- Series A
- $13,700,000
Pomerium is a zero-trust reverse proxy that helps enterprises manage secure application access.
---
Authenticate, authorize, monitor, and secure user access to any application without a VPN.
Access driven by identity and context.
----
Use your existing identity provider, such as Okta, Active Directory, Google, Gsuite, or OneLogin to add single-sign-on authentication to any application with Pomerium.
Add access control to any app.
---
Pomerium provides a standardized interface to add access control whether an application itself has authorization or authentication baked-in. Let developers focus on their apps, not reinventing access control.
- Industry Software Development
- Website https://www.pomerium.com/
- LinkedIn https://www.linkedin.com/company/pomerium-inc/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)